• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β3-肾上腺素能激动剂BRL35135A对大鼠骨骼肌体内及体外葡萄糖摄取的影响。

Effect of a beta 3-adrenergic agonist, BRL35135A, on glucose uptake in rat skeletal muscle in vivo and in vitro.

作者信息

Abe H, Minokoshi Y, Shimazu T

机构信息

Department of Medical Biochemistry, Ehime University School of Medicine, Japan.

出版信息

J Endocrinol. 1993 Dec;139(3):479-86. doi: 10.1677/joe.0.1390479.

DOI:10.1677/joe.0.1390479
PMID:7907647
Abstract

The effects of the beta 3-agonist, BRL35135A, on glucose uptake in the peripheral tissues of the rat, including skeletal muscle, were studied using the 2-[3H]deoxyglucose method in anaesthetized adult animals. Intravenous infusion of the beta 3-agonist dose-dependently increased the rate constant of glucose uptake in three types of skeletal muscle, brown adipose tissue, white adipose tissue, heart and diaphragm, but not in the brain, spleen or lung. Although infusion of the beta 3-agonist did not change the plasma concentration of glucose appreciably, it caused an increase in the plasma concentration of insulin when given at more than 25 micrograms/kg per h. To ascertain whether the effect of the beta 3-agonist on glucose uptake in skeletal muscle is mediated by insulin, glucose uptake into soleus muscle isolated from young rats was also measured in vitro using different concentrations of the beta 3-agonist. The beta 3-agonist BRL37344 (an active metabolite of BRL35135A) significantly increased glucose transport in a dose-dependent manner, with maximum stimulation at 100 pmol/l. These results demonstrate that glucose uptake in skeletal muscle can be enhanced independently of the action of insulin, probably through the mediation of beta 3-adrenoceptors present in the tissue.

摘要

利用2-[³H]脱氧葡萄糖法,在麻醉的成年动物中研究了β3-激动剂BRL35135A对大鼠外周组织(包括骨骼肌)葡萄糖摄取的影响。静脉输注β3-激动剂可使三种类型的骨骼肌、棕色脂肪组织、白色脂肪组织、心脏和膈肌中葡萄糖摄取的速率常数呈剂量依赖性增加,但对脑、脾或肺无此作用。尽管输注β3-激动剂并未明显改变血浆葡萄糖浓度,但当以每小时超过25微克/千克的剂量给药时,会导致血浆胰岛素浓度升高。为了确定β3-激动剂对骨骼肌葡萄糖摄取的作用是否由胰岛素介导,还使用不同浓度的β3-激动剂在体外测量了从幼鼠分离的比目鱼肌中的葡萄糖摄取。β3-激动剂BRL37344(BRL35135A的活性代谢产物)以剂量依赖性方式显著增加葡萄糖转运,在100皮摩尔/升时达到最大刺激。这些结果表明,骨骼肌中的葡萄糖摄取可能通过组织中存在的β3-肾上腺素能受体介导,独立于胰岛素的作用而增强。

相似文献

1
Effect of a beta 3-adrenergic agonist, BRL35135A, on glucose uptake in rat skeletal muscle in vivo and in vitro.β3-肾上腺素能激动剂BRL35135A对大鼠骨骼肌体内及体外葡萄糖摄取的影响。
J Endocrinol. 1993 Dec;139(3):479-86. doi: 10.1677/joe.0.1390479.
2
Acute effects of the beta 3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation.β3-肾上腺素能受体激动剂BRL 35135对组织葡萄糖利用的急性影响。
Br J Pharmacol. 1995 Feb;114(4):888-94. doi: 10.1111/j.1476-5381.1995.tb13287.x.
3
Improvement of metabolic disorders and visceral fat obesity by the beta 3-adrenoceptor agonist (R*,R*)-(+/-)-methyl-4-[2-[2-hydroxy-2 -(3-chlorophenyl)ethylamino]propyl]-phenoxyacetate hydrobromide (BRL35135A) in genetically obese rodents.β3-肾上腺素能受体激动剂(R*,R*)-(±)-甲基-4-[2-[2-羟基-2-(3-氯苯基)乙氨基]丙基]-苯氧基乙酸氢溴酸盐(BRL35135A)对遗传性肥胖啮齿动物代谢紊乱和内脏脂肪肥胖的改善作用
Biochem Pharmacol. 1996 Nov 22;52(10):1529-35. doi: 10.1016/s0006-2952(96)00552-7.
4
CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats.CL-316,243,一种β3特异性肾上腺素能受体激动剂,可增强非肥胖大鼠胰岛素刺激的葡萄糖代谢。
Diabetes. 1997 Aug;46(8):1257-63. doi: 10.2337/diab.46.8.1257.
5
Glucose uptake of the muscle and adipose tissues in diabetes and obesity disease models: evaluation of insulin and β3-adrenergic receptor agonist effects by F-FDG.糖尿病和肥胖症疾病模型中肌肉和脂肪组织的葡萄糖摄取:用F-FDG评估胰岛素和β3-肾上腺素能受体激动剂的作用
Ann Nucl Med. 2017 Jun;31(5):413-423. doi: 10.1007/s12149-017-1169-0. Epub 2017 Apr 11.
6
Beta2-adrenoceptors and non-beta-adrenoceptors mediate effects of BRL37344 and clenbuterol on glucose uptake in soleus muscle: studies using knockout mice.β2-肾上腺素能受体和非β-肾上腺素能受体介导 BRL37344 和克仑特罗对跖肌葡萄糖摄取的影响:使用基因敲除小鼠的研究。
Br J Pharmacol. 2009 Dec;158(7):1676-82. doi: 10.1111/j.1476-5381.2009.00472.x.
7
Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle.β-肾上腺素能受体激动剂BRL 37344对大鼠离体骨骼肌葡萄糖利用的双相作用。
Br J Pharmacol. 1996 Mar;117(6):1355-61. doi: 10.1111/j.1476-5381.1996.tb16736.x.
8
Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats.大鼠下丘脑内注射瘦素后交感神经系统和胰岛素在增强外周组织葡萄糖摄取中的作用
Diabetes. 1999 Sep;48(9):1706-12. doi: 10.2337/diabetes.48.9.1706.
9
The beta3-adrenergic agonist BRL37344 increases glucose transport into L6 myocytes through a mechanism different from that of insulin.β3-肾上腺素能激动剂BRL37344通过一种不同于胰岛素的机制增加葡萄糖转运进入L6肌细胞。
J Biochem. 1997 Jul;122(1):90-5. doi: 10.1093/oxfordjournals.jbchem.a021744.
10
Acute exposure of primary rat soleus muscle to zilpaterol HCl (β2 adrenergic agonist), TNFα, or IL-6 in culture increases glucose oxidation rates independent of the impact on insulin signaling or glucose uptake.原代大鼠比目鱼肌在培养中急性暴露于盐酸齐帕特罗(β2肾上腺素能激动剂)、肿瘤坏死因子α或白细胞介素-6下,可提高葡萄糖氧化速率,且与对胰岛素信号传导或葡萄糖摄取的影响无关。
Cytokine. 2017 Aug;96:107-113. doi: 10.1016/j.cyto.2017.03.014. Epub 2017 Apr 5.

引用本文的文献

1
Physiological and metabolic functions of the β-adrenergic receptor and an approach to therapeutic achievements.β-肾上腺素能受体的生理和代谢功能及治疗成果的实现途径。
J Physiol Biochem. 2024 Nov;80(4):757-774. doi: 10.1007/s13105-024-01040-z. Epub 2024 Aug 15.
2
Is the β-Adrenoceptor a Valid Target for the Treatment of Obesity and/or Type 2 Diabetes?β-肾上腺素受体是否是肥胖症和/或 2 型糖尿病治疗的有效靶点?
Biomolecules. 2023 Nov 28;13(12):1714. doi: 10.3390/biom13121714.
3
Physiological and molecular mechanisms of cold-induced improvements in glucose homeostasis in humans beyond brown adipose tissue.
除褐色脂肪组织外,寒冷诱导人体葡萄糖稳态改善的生理和分子机制。
Int J Obes (Lond). 2023 May;47(5):338-347. doi: 10.1038/s41366-023-01270-z. Epub 2023 Feb 11.
4
The β2-adrenergic receptor in the apical membrane of intestinal enterocytes senses sugars to stimulate glucose uptake from the gut.肠道肠上皮细胞顶端膜中的β2 - 肾上腺素能受体感知糖类,以刺激肠道对葡萄糖的摄取。
Front Cell Dev Biol. 2023 Jan 9;10:1041930. doi: 10.3389/fcell.2022.1041930. eCollection 2022.
5
Alpha2delta-1 in SF1 Neurons of the Ventromedial Hypothalamus Is an Essential Regulator of Glucose and Lipid Homeostasis.室旁核 SF1 神经元中的 Alpha2delta-1 是葡萄糖和脂质稳态的重要调节因子。
Cell Rep. 2017 Dec 5;21(10):2737-2747. doi: 10.1016/j.celrep.2017.11.048.
6
Enhanced sympathetic activity in mice with brown adipose tissue transplantation (transBATation).棕色脂肪组织移植(transBATation)小鼠的交感神经活动增强。
Physiol Behav. 2014 Feb 10;125:21-9. doi: 10.1016/j.physbeh.2013.11.008. Epub 2013 Nov 27.
7
β2-adrenoceptor agonists can both stimulate and inhibit glucose uptake in mouse soleus muscle through ligand-directed signalling.β2-肾上腺素受体激动剂可通过配体定向信号传导,既刺激又抑制小鼠比目鱼肌的葡萄糖摄取。
Naunyn Schmiedebergs Arch Pharmacol. 2013 Sep;386(9):761-73. doi: 10.1007/s00210-013-0860-5. Epub 2013 Apr 6.
8
β(2)-Adrenoceptors increase translocation of GLUT4 via GPCR kinase sites in the receptor C-terminal tail.β(2)-肾上腺素受体通过受体 C 末端尾部的 G 蛋白偶联受体激酶位点增加 GLUT4 的易位。
Br J Pharmacol. 2012 Mar;165(5):1442-56. doi: 10.1111/j.1476-5381.2011.01647.x.
9
Study of glucose uptake activity of Helicteres isora Linn. fruits in L-6 cell lines.对金铃子果实提取物在L-6细胞系中的葡萄糖摄取活性的研究。
Int J Diabetes Dev Ctries. 2009 Oct;29(4):170-3. doi: 10.4103/0973-3930.57349.
10
Beta2-adrenoceptors and non-beta-adrenoceptors mediate effects of BRL37344 and clenbuterol on glucose uptake in soleus muscle: studies using knockout mice.β2-肾上腺素能受体和非β-肾上腺素能受体介导 BRL37344 和克仑特罗对跖肌葡萄糖摄取的影响:使用基因敲除小鼠的研究。
Br J Pharmacol. 2009 Dec;158(7):1676-82. doi: 10.1111/j.1476-5381.2009.00472.x.